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Fatal course of Churg-Strauss disease
Abstract
Churg-Strauss syndrome (CSS) is an allergic vasculitis, which is commonly characterized by asthma and
allergic rhinitis, eosinophila and eosinophillic infiltration of organs. Approximately 60–90% of patients with
CSS are long-term survivors. We presented the case of fatal case of the disease complicated by pulmonary
embolism, arrhythmia, and eventually — cerebral bleeding.
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Introduction
Asthma is a chronic inflammatory disease [1],
which in the majority of patients may be sufficiently
controlled. However, in some cases, in spite of prop-
er treatment the disease progresses and the full con-
trol of symptoms is difficult to achieve. Several fac-
tors have been identified as triggers of the course of
asthma, including aspirin intolerance, cigarette smok-
ing, GERD, infections caused by Chlamydia pneu-
moniae. In some cases an uncontrolled asthma may
be associated with disorders of different than asth-
ma origin, like Churg-Strauss syndrome (CSS), which
is an allergic vasculitis.
In this paper the case of fatal course of CSS,
which presented mainly as asthma, is described.
Case report
Male patient (W.D). 63-years-old, was admitted
at the Allergology Department on 11.02.2005 due to
hemoptysis in the course of asthma, which was diag-
nosed a few years before. His asthma was poorly
controlled and it exacerbated frequently with the need
for oral steroids. In the early nineties he experienced
pulmonary insufficiency and required respiratory
management after surgical treatment of abdominal
hernia. In 2005 he had intracerebral haematoma. He
had a history of lung tuberculosis treated with tuber-
culostatics and complicated by empyema.
At the time of admission patients was mildly
short of breath, with mild hemoptysis; auscultation
revealed sporadic wheezing.
Spirometry showed moderate bronchial obstruc-
tion with good reversibility (sFEV1 over 12%; 206 ml).
Chest X-ray was normal, whereas ground glass opaci-
fications were present in high resolution computed
tomography. Blood eosinophils were markedly in-
creased (1500/mm), blood cell sedimentation was
35mm/h and CRP — 33 mg/l.
Thus the preliminary diagnosis of CSS was pro-
posed. There were no signs or symptoms of other
organs involvement — blood markers of kidney func-
tion and urine analysis were normal, ECG and cardi-
ac enzymes (CK-MD, troponin 1) were normal, oto-
laryngological and neurological assessment were
normal. D-dimmer was beneath 500 mg/L. Some lab-
oratory abnormalities, however, were identified
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— LDH was increased — 365 U/L, APTT — 36 sec,
fibrinogen — 4.92 g/l, protein electrophoresis
showed slightly increased alfa-1 protein. ANA test
was moderately increased (80 U/L), ANCA were ab-
sent. The final diagnosis of CSS disease was made
and patient received oral prednisone (total daily dose
— 1mg/kg). On 19.02.2005 sudden severe dyspnea
and critical hypotension occurred. Patient was intu-
bated and administered to Cardiology Department,
where pulmonary embolism was diagnosed and he
received fibrinolytic treatment, dopamine and dob-
utamine, oral prednisone was changed to intrave-
nous solu-medrol and cyclophosphamide. During
following three days recurrent supraventricular ex-
trasystolia, and eventually atrial fibrillation were ob-
served. At that time serum level of troponine 1 was
0.66, CK-MB — 5.8, CRP — 183, D-dimmer — 785.
Intravenous amiodarone and cardioversy failed to
control heart rhythm. Increasing respiratory and car-
diac failure required invasive ventilation and heart
stimulation and patient was referred to the Intensive
Care Unit (24.02.2005). During the following days
his status has been improving, his cardiovascular and
respiratory system become efficient two days later
and he was extubated on 01.03.2005. Patient con-
tinued anticoagulative treatment,and solumedrol.
On 03.03.2005 patient deteriorated rapidly, he
required re-intubation, head CT scans showed mas-
sive hematoma (9 ¥ 6 cm) in the right hemisphere,
with blood present in the brain chambers’ system,
left lateral herniation under the falx and massive
brain oedema. Consultant of neurology affirmed the
“death of the brain stem”. Patient died on
06.03.2005 with signs and symptoms of DIC and
multi-organ insufficiency.
Discussion
Churg-Strauss syndrome is a multi-organ disor-
der. Characteristic triad of symptoms includes asth-
ma, eosinophilia, and organs involvement due to
eosinophils infiltrations of vessels.
Usually small and medium-sized arteries are in-
volved. Paranasal sinusitis, pulmonary and renal in-
filtrates, mononeuritis multiplex or polyneuropathy,
allergic rhinitis, gastroenteritis and skin lesions are
common presentations of the disease.
In the proportion of patients with vasculitis an-
tineutrophil cytoplasmic antibodies (ANCA) against
myeloperoxidase (MPO) and against proteinase 3
(PR3) may be identified. The former are usually asso-
ciated with CSS [2]. Goncalves et al. postulated even
that antineutrophil cytoplasmic antibody (ANCA)
assessment in chronic rhinosinusitis might allow for
early identifying vascilitis [3]. In the presented case
ANCA test was negative, however moderate increase
in the level of antinuclear antibodies (ANA) was
found. Although ANA test is typically positive in rheu-
matoid diseases rather than in CSS, some patients
may have weakly increased levels of ANA and/or
rheumatoid factor (RF) [4].
The American College of Rheumatology (ACR)
has proposed 6 criteria for the diagnosis of CSS:
— asthma (wheezing, expiratory rhonchi);
— eosinophilia of more than 10% in peripheral
blood;
— paranasal sinusitis;
— pulmonary infiltrates (may be transient);
— histological proof of vasculitis with extravascular
eosinophils;
— mononeuritis multiplex or polyneuropathy.
The presence of four or more criteria yields a
sensitivity of 85% and a specificity of 99.7%. In the
presented case, at the time of admission to the De-
partment of Allergology, three criteria were actually
fulfilled — asthma, eosinophilia and pulmonary in-
volvement. However, hemoptysis and CT high reso-
lution findings indicated pulmonary angitis, the con-
dition which required systemic treatment [5]. He-
moptysis, which occurred in patient were most prob-
ably related to pulmonary alveolar hemorrhage re-
sulting from alveolar capillaritis.
Cardiac manifestation of the disease (28%) is
not rare and symptoms are usually related to heart
failure, infarction, myocarditis, pericarditis, constric-
tive pericarditis [6]. Thromboembolic disease is much
more rare occurrence. Recently Gracia et al reported
three cases of severe pulmonary embolism [7]. In-
terestingly in all these patients, similarly to ours,
ANCA were negative. They all presented with deep
vein thrombosis revealed by Doppler ultrasonogra-
phy. In our patients such an assessment was not
done, because of his critical condition, when mas-
sive pulmonary embolism had appeared.
Current therapeutic approach in CSS includes
prednisone, usually combined with cyclophospha-
mide, metothrexate or azathioprine. Although with
this regimen response may be frequently reached
it is toxic and does not prevent relapse [8]. Long-
term treatment may be the risk for thrombo-em-
bolic disease, but it was not the case in our patient,
who received steroid for a few day only before
embolic incident. Vessels inflammation, particular-
ly associated with eosinophilic infiltrates may in-
crease the frequency of local thrombotic complica-
tions, which in turn may result in pulmonary em-
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bolism. Incident of pulmonary embolism prior to
steroidotherapy was previously described in 13-year-
old boy with CSS [9].
Long term survival in the entire group of pa-
tients with CSS is good, approximately 60–90%.
Even patients with severe active disease may ex-
perience remission. In our case, however massive
pulmonary embolism was complicated with arrhyth-
mia, and further with severe cerebral bleeding.
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